ArticleBritish journal of pharmacology2013

Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

Kenneth K W To et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.